“Ajinomoto Bio-Pharma Services Platform Technologies” website released

On June 30, 2022, Ajinomoto Bio-Pharma Services launched the website “Ajinomoto Bio-Pharma Services Platform Technologies”, introducing our proprietary platform technologies.

This website details our innovative proprietary platform technologies, AJIPHASE® oligonucleotide manufacturing technology, CORYNEX®/TALAMAX® protein expression system, AJICAP® site-specific conjugation technology for ADC.

In the future, we will dispatch additional information on the technologies of Ajinomoto Bio-pharma Services through this website.